American Journal of Respiratory and Critical Care Medicine

Koichi Miyashita, Hironao Hozumi, Kazuki Furuhashi, Eiji Nakatani, Yusuke Inoue, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Noriyuki Enomoto, Tomoyuki Fujisawa, Naoki Inui, Toshiyuki Ojima, Takafumi Suda. (2024) Impact of preexisting interstitial lung disease on mortality in COVID-19 patients from the early pandemic to the delta variant epidemic: a nationwide population-based study. Respiratory Research 25:1.
Online publication date: 21-Feb-2024.
Crossref
Kyung-Shin Lee, Min Jin Go, Youn Young Choi, Min-Kyung Kim, Jaehyun Seong, Ho Kyung Sung, Jaehyun Jeon, Hee-Chang Jang, Myoung-Hee Kim, Robert Jeenchen Chen. (2024) Risk factors for critical COVID-19 illness during Delta- and Omicron-predominant period in Korea; using K-COV-N cohort in the National health insurance service. PLOS ONE 19:3, e0300306.
Online publication date: 14-Mar-2024.
Crossref
John A. Mackintosh, Gregory Keir, Lauren K. Troy, Anne E. Holland, Christopher Grainge, Daniel C. Chambers, Debra Sandford, Helen E. Jo, Ian Glaspole, Margaret Wilsher, Nicole S. L. Goh, Paul N. Reynolds, Sally Chapman, Steven E. Mutsaers, Sally de Boer, Susanne Webster, Yuben Moodley, Tamera J. Corte. (2024) Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision. Respirology 29:2, 105-135.
Online publication date: 11-Jan-2024.
Crossref
Chao-Hsien Chen, Cheng-Yi Wang, Ching-Yi Chen, Ya-Hui Wang, Kuang-Hung Chen, Chih-Cheng Lai, Yu-Feng Wei, Pin-Kuei Fu, Dong Keon Yon. (2024) The influence of prior use of inhaled corticosteroids on COVID-19 outcomes: A systematic review and meta-analysis. PLOS ONE 19:1, e0295366.
Online publication date: 19-Jan-2024.
Crossref
Malihe Safari, Fatemeh Ghadamgahi, Javad Faradmal, Saeid Bashirian, Ali Reza Soltanian, Salman Khazaei, Ghodratollah Roshanaei. (2024) Evaluating the Effect of Underlying Pulmonary Disease on the Clinical Outcome and survival among Patients with COVID-19: Using Propensity Score Matching. The Open Public Health Journal 17:1.
Online publication date: 12-Jan-2024.
Crossref
Gabriella Tikellis, Tamera Corte, Ian N Glaspole, Nicole S L Goh, Yet H Khor, Jeremy Wrobel, Karen Symons, Lisa Fuhrmeister, Laura Glenn, Shiji Chirayath, Lauren K Troy, Bill King, Anne E Holland. (2024) Navigating the COVID-19 pandemic: Experiences and self-management approaches adopted by people with interstitial lung disease. Chronic Respiratory Disease 21.
Online publication date: 9-Jan-2024.
Crossref
Gabriella Tikellis, Tamera Corte, Ian N. Glaspole, Nicole Goh, Yet H. Khor, Jeremy Wrobel, Karen Symons, Lisa Fuhrmeister, Laura Glenn, Shiji Chirayath, Lauren Troy, Anne E. Holland. (2023) Understanding the telehealth experience of care by people with ILD during the COVID-19 pandemic: what have we learnt?. BMC Pulmonary Medicine 23:1.
Online publication date: 6-Apr-2023.
Crossref
Ana Karem S. Pruneda, José Omar Barreto-Rodríguez, Moises Selman, Fortunato Juárez-Hernández, Ivette Buendía-Roldán. (2023) Mortality in patients with interstitial lung diseases hospitalized by severe or critical COVID-19. BMC Pulmonary Medicine 23:1.
Online publication date: 13-Oct-2023.
Crossref
Ioanna Nikitopoulou, Alice G. Vassiliou, Nikolaos Athanasiou, Edison Jahaj, Karolina Akinosoglou, Ioanna Dimopoulou, Stylianos E. Orfanos, Vasiliki Dimakopoulou, Georgios Schinas, Argyrios Tzouvelekis, Vassilis Aidinis, Anastasia Kotanidou. (2023) Increased Levels of Galectin-3 in Critical COVID-19. International Journal of Molecular Sciences 24:21, 15833.
Online publication date: 31-Oct-2023.
Crossref
Masahiro Nemoto, Chi Wan Koo, Paul D. Scanlon, Jay H. Ryu. (2023) Combined Pulmonary Fibrosis and Emphysema. Mayo Clinic Proceedings 98:11, 1685-1696.
Online publication date: 1-Nov-2023.
Crossref
Daniel Kramer, Robert Hilton, Jesse Roman. (2023) Pulmonary fibrosis and COVID-19. The American Journal of the Medical Sciences 366:4, 245-253.
Online publication date: 1-Oct-2023.
Crossref
Jun Fukihara, Yasuhiro Kondoh. (2023) COVID-19 and interstitial lung diseases: A multifaceted look at the relationship between the two diseases. Respiratory Investigation 61:5, 601-617.
Online publication date: 1-Sep-2023.
Crossref
Noemi Suppini, Ovidiu Fira-Mladinescu, Daniel Traila, Alexandru Catalin Motofelea, Monica Steluta Marc, Diana Manolescu, Emanuela Vastag, Ram Kiran Maganti, Cristian Oancea. (2023) Longitudinal Analysis of Pulmonary Function Impairment One Year Post-COVID-19: A Single-Center Study. Journal of Personalized Medicine 13:8, 1190.
Online publication date: 26-Jul-2023.
Crossref
Toru Arai, Yu Kurahara, Mitsuhiro Moda, Takehiko Kobayashi, Yoshinobu Matsuda, Tomoko Kagawa, Reiko Sugawara, Kazunari Tsuyuguchi, Yoshikazu Inoue. (2023) COVID-19 in Patients with Pre-Existing Interstitial Lung Disease: Potential Value of a Steroid-Based Treatment Strategy. Journal of Clinical Medicine 12:15, 4940.
Online publication date: 27-Jul-2023.
Crossref
Daria Apostolo, Luciana L. Ferreira, Alice Di Tizio, Barbara Ruaro, Filippo Patrucco, Mattia Bellan. (2023) A Review: The Potential Involvement of Growth Arrest-Specific 6 and Its Receptors in the Pathogenesis of Lung Damage and in Coronavirus Disease 2019. Microorganisms 11:8, 2038.
Online publication date: 8-Aug-2023.
Crossref
Jiahao Zhu, Dan Zhou, Jing Wang, Ye Yang, Dingwan Chen, Fan He, Yingjun Li. (2023) A Causal Atlas on Comorbidities in Idiopathic Pulmonary Fibrosis. CHEST 164:2, 429-440.
Online publication date: 1-Aug-2023.
Crossref
Domingo Franco-Palacios, Lisa Allenspach, Lisa Stagner, Kelly Bryce, Jane Simanovski, Hassan Nemeh. (2023) Lung Transplantation for COVID-19 Related Lung Disease: A Follow-Up Study of Outcomes from a Medium-Size Lung Transplant Programd. OBM Transplantation 07:03, 1-25.
Online publication date: 17-Jul-2023.
Crossref
Sevtap Doğan, Gözde Selvi Güldiken, Burcu Alpaslan, Serap Argun Barış, Nurettin Özgür Doğan. (2023) Impact of COVID-19 pneumonia on interstitial lung disease: semi-quantitative evaluation with computed tomography. European Radiology 33:7, 4758-4766.
Online publication date: 11-Feb-2023.
Crossref
Francisco Javier Candel, Pablo Barreiro, Miguel Salavert, Alfonso Cabello, Mario Fernández-Ruiz, Pedro Pérez-Segura, Jesús San Román, Juan Berenguer, Raúl Córdoba, Rafael Delgado, Pedro Pablo España, Ignacio Alberto Gómez-Centurión, Juan María González del Castillo, Sarah Béatrice Heili, Francisco Javier Martínez-Peromingo, Rosario Menéndez, Santiago Moreno, José Luís Pablos, Juan Pasquau, José Luis Piñana. (2023) Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2. Viruses 15:7, 1449.
Online publication date: 27-Jun-2023.
Crossref
Rachel L. Williams, Catherine Hyams, Joe Robertshaw, Maria Garcia Gonzalez, Zsuzsa Szasz-Benczur, Paul White, Nick A. Maskell, Adam Finn, Shaney L. Barratt, David Adegbite, Rupert Antico, Francesca Bayley, Beth Begier, Maddalena Bellavia, Emma Bridgeman, Julia Brzezinska, James Campling, Natalie Chang, Julie Cloake, Madeleine Clout, Pip Croxford, Gillian Ellsbury, Bradford Gessner, Niall Grace, Sharon Gray, Oliver Griffiths, Charli Grimes, Lucy Grimwood, Zsolt Friedrich, Leah Fleming, Kazminder Fox, Milo Jeenes-Flanagan, Luis Jodar, Johanna Kellett Wright, Jane Kinney, Robyn Heath, Kate Helliker, Robyn Huber, Amelia Langdon, Rajeka Lazarus, Sandi Nammuni Arachchge, Vicki Mackay, Robin Marlow, Zandile Maseko, Anya Mattocks, Katie Maughan, Nicola Manning, Katarina Milutinovic, Konstantina Minou, Anna Morley, Taslima Mona, Claire Mitchell, Leigh Morrison, Bethany Osborne, Fiona Perkins, Tawassal Riaz, Gabriella Ruffino, Peter Sequenza, Lily Smart, Emma Scott, Jo Southern, Seevakumar Suppiah, Zoe Taylor, Grace Tilzey, Anabella Turner, Gabriella Valentine, Marianne Vasquez, Rhian Walters, Lana Ward, Louise Wright. (2023) Use of illness severity scores to predict mortality in interstitial lung disease patients hospitalised with acute respiratory deterioration. Respiratory Medicine 212, 107220.
Online publication date: 1-Jun-2023.
Crossref
Stylianos Panopoulos, Vasilios Tzilas, Vasiliki-Kalliopi Bournia, Anastasios Karamanakos, Katerina Laskari, Demosthenes Bouros, Maria Tektonidou, Petros P. Sfikakis. (2023) COVID-19 and protection of vaccination in patients with systemic sclerosis–associated interstitial lung disease. Journal of Scleroderma and Related Disorders 8:2, 113-119.
Online publication date: 13-Dec-2022.
Crossref
Vincent Cottin, Philippe Bonniaud, Jacques Cadranel, Bruno Crestani, Stéphane Jouneau, Sylvain Marchand-Adam, Hilario Nunes, Lidwine Wémeau-Stervinou, Emmanuel Bergot, Elodie Blanchard, Raphaël Borie, Arnaud Bourdin, Cécile Chenivesse, Annick Clément, Emmanuel Gomez, Anne Gondouin, Sandrine Hirschi, François Lebargy, Charles-Hugo Marquette, David Montani, Grégoire Prévot, Sébastien Quetant, Martine Reynaud-Gaubert, Mathieu Salaun, Olivier Sanchez, Bruno Trumbic, Karim Berkani, Pierre-Yves Brillet, Marion Campana, Lara Chalabreysse, Gérard Chatté, Didier Debieuvre, Gilbert Ferretti, Jean-Michel Fourrier, Nicolas Just, Marianne Kambouchner, Bertrand Legrand, Frédéric Le Guillou, Jean-Pierre Lhuillier, Anas Mehdaoui, Jean-Marc Naccache, Catherine Paganon, Martine Rémy-Jardin, Salim Si-Mohamed, Philippe Terrioux. (2023) French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version. Respiratory Medicine and Research 83, 100948.
Online publication date: 1-Jun-2023.
Crossref
Luciane Almeida Amado, Wagner Luis da Costa Nunes Pimentel Coelho, Arthur Daniel Rocha Alves, Vanessa Cristine de Souza Carneiro, Otacilio da Cruz Moreira, Vanessa Salete de Paula, Andreza Salvio Lemos, Larissa Araujo Duarte, Elisa Gouvea Gutman, Fabricia Lima Fontes-Dantas, João Paulo da Costa Gonçalves, Carlos Henrique Ferreira Ramos, Carlos Henrique Ferreira Ramos Filho, Marta Guimarães Cavalcanti, Marisa Pimentel Amaro, Rafael Lopes Kader, Roberto de Andrade Medronho, Dmitry José de Santana Sarmento, Soniza Vieira Alves-Leon. (2023) Clinical Profile and Risk Factors for Severe COVID-19 in Hospitalized Patients from Rio de Janeiro, Brazil: Comparison between the First and Second Pandemic Waves. Journal of Clinical Medicine 12:7, 2568.
Online publication date: 29-Mar-2023.
Crossref
Filippo Patrucco, Paolo Solidoro, Francesco Gavelli, Daria Apostolo, Mattia Bellan. (2023) Idiopathic Pulmonary Fibrosis and Post-COVID-19 Lung Fibrosis: Links and Risks. Microorganisms 11:4, 895.
Online publication date: 30-Mar-2023.
Crossref
Anna J. Podolanczuk, Carey C. Thomson, Martine Remy-Jardin, Luca Richeldi, Fernando J. Martinez, Martin Kolb, Ganesh Raghu. (2023) Idiopathic pulmonary fibrosis: state of the art for 2023. European Respiratory Journal 61:4, 2200957.
Online publication date: 26-Jan-2023.
Crossref
Elisa Martínez-Besteiro, María Molina-Molina, Anna Michela Gaeta, Myriam Aburto, Álvaro Casanova, Juan Rigual Bobillo, Sandra Orozco, Raquel Pérez Rojo, Raúl Godoy, Belén López-Muñiz Ballesteros, Erwin Javier Pinillos Robles, Susana Sánchez Fraga, Teresa Peña Miguel, Eva Balcells, Rosalía Laporta, Jose Antonio Rodríguez Portal, Susana Herrera Lara, Eva Cabrera, Orlando Acosta, Adrián Peláez, Claudia Valenzuela. (2023) Impact of COVID-19 Infection on Patients with Preexisting Interstitial Lung Disease: A Spanish Multicentre Study. Archivos de Bronconeumología 59:4, 273-276.
Online publication date: 1-Apr-2023.
Crossref
Kevin Chevalier, Michaël Genin, Thomas Petit Jean, Jerôme Avouac, Rene-Marc Flipo, Sophie Georgin-Lavialle, Soumaya El Mahou, Edouard Pertuiset, Thao Pham, Amelie Servettaz, Hubert Marotte, Fanny Domont, Pascal Chazerain, Mathilde Devaux, Arsene Mekinian, Jérémie Sellam, Bruno Fautrel, Diane Rouzaud, Esther Ebstein, Nathalie Costedoat-Chalumeau, Christophe Richez, Eric Hachulla, Xavier Mariette, Raphaèle Seror. (2023) CovAID: Identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseases. Frontiers in Medicine 10.
Online publication date: 22-Mar-2023.
Crossref
Huixun Du, Juliet M. Bartleson, Sergei Butenko, Valentina Alonso, Wendy F. Liu, Daniel A. Winer, Manish J. Butte. (2023) Tuning immunity through tissue mechanotransduction. Nature Reviews Immunology 23:3, 174-188.
Online publication date: 16-Aug-2022.
Crossref
Jürgen Behr, Melanie Berger, Torsten Gerriet Blum, Francesco Bonella, Julien Dinkel, Sven Gläser, Lars Hagmeyer, Nikolaus Kneidinger, Dirk Koschel, Antje Prasse, Hortense Slevogt, Elvira Stacher-Priehse, Holger Woehrle, Michael Kreuter. (2023) SARS-CoV-2-Infektion und interstitielle Lungenerkrankungen – Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin. Pneumologie 77:03, 143-157.
Online publication date: 14-Mar-2023.
Crossref
Abenaya Muralidharan, Christopher D. Bauer, Dawn M. Katafiasz, Heather M. Strah, Aleem Siddique, St Patrick Reid, Kristina L. Bailey, Todd A. Wyatt. (2023) Synergistic Detrimental Effects of Cigarette Smoke, Alcohol, and SARS-CoV-2 in COPD Bronchial Epithelial Cells. Pathogens 12:3, 498.
Online publication date: 22-Mar-2023.
Crossref
Rishabh Hirawat, Namrata Jain, Mohd Aslam Saifi, Mahesh Rachamalla, Chandraiah Godugu. (2023) Lung fibrosis: Post-COVID-19 complications and evidences. International Immunopharmacology 116, 109418.
Online publication date: 1-Mar-2023.
Crossref
Roengrudee Patanavanich, Tanatorn Siripoon, Salin Amponnavarat, Stanton A Glantz. (2023) Active Smokers Are at Higher Risk of COVID-19 Death: A Systematic Review and Meta-analysis. Nicotine & Tobacco Research 25:2, 177-184.
Online publication date: 1-Apr-2022.
Crossref
Levente Zsichla, Viktor Müller. (2023) Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors. Viruses 15:1, 175.
Online publication date: 7-Jan-2023.
Crossref
Paula Rodriguez-Miguelez, Allison Heefner, Salvatore Carbone. (2023) Recognizing risk factors associated with poor outcomes among patients with COVID-19. Progress in Cardiovascular Diseases 76, 3-11.
Online publication date: 1-Jan-2023.
Crossref
Priyanka Roy, Mainak Bardhan, Shubhajeet Roy, Utkarsh Singh, Timil Suresh, Ayush Anand. (2023) Silico-tuberculosis amidst COVID-19 pandemic: global scenario and Indian perspective. Annals of Medicine & Surgery 85:12, 6083-6090.
Online publication date: 1-Dec-2023.
Crossref
Abenaya Muralidharan, Christopher Bauer, Dawn M. Katafiasz, Danielle Pham, Opeoluwa O. Oyewole, M. Jane Morwitzer, Enakshi Roy, Kristina L. Bailey, St Patrick Reid, Todd A. Wyatt. (2023) Malondialdehyde acetaldehyde adduction of surfactant protein D attenuates SARS‐CoV ‐2 spike protein binding and virus neutralization. Alcohol: Clinical and Experimental Research 47:1, 95-103.
Online publication date: 20-Nov-2022.
Crossref
Dionysios Fanidis, Vasileios C. Pezoulas, Dimitrios I. Fotiadis, Vassilis Aidinis. (2023) An explainable machine learning-driven proposal of pulmonary fibrosis biomarkers. Computational and Structural Biotechnology Journal 21, 2305-2315.
Online publication date: 1-Jan-2023.
Crossref
Mohd Arish, Wei Qian, Harish Narasimhan, Jie Sun. (2023) COVID‐19 immunopathology: From acute diseases to chronic sequelae. Journal of Medical Virology 95:1.
Online publication date: 13-Sep-2022.
Crossref
Barak Pertzov, Einat Shmueli, Haim Ben Zvi, Amir Massarweh, Tamar Barkan, Asaf Ness, Yael Shostak, Lev Freidkin, Osnat Shtraichman, Mordechai R. Kramer. (2022) Humoral response among patients with interstitial lung disease vaccinated with the BNT162b2 SARS-Cov-2 vaccine: a prospective cohort study. Respiratory Research 23:1.
Online publication date: 1-Sep-2022.
Crossref
Riccardo Scotto, Amedeo Lanzardo, Antonio Riccardo Buonomo, Biagio Pinchera, Letizia Cattaneo, Alessia Sardanelli, Simona Mercinelli, Giulio Viceconte, Alessandro Perrella, Vincenzo Esposito, Alessio Vinicio Codella, Paolo Maggi, Emanuela Zappulo, Riccardo Villari, Maria Foggia, Ivan Gentile, . (2022) A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19. Vaccines 10:12, 2043.
Online publication date: 29-Nov-2022.
Crossref
Yoko Miura, Hirotsugu Ohkubo, Akiko Nakano, Jane E. Bourke, Satoshi Kanazawa. (2022) Pathophysiological conditions induced by SARS-CoV-2 infection reduce ACE2 expression in the lung. Frontiers in Immunology 13.
Online publication date: 4-Nov-2022.
Crossref
Gabriel Figueroa-Parra, Emily L Gilbert, Maria O Valenzuela-Almada, Sebastian Vallejo, Matthew R Neville, Naomi J Patel, Claire Cook, Xiaoqing Fu, Ramla Hagi, Gregory C McDermott, Michael A Dilorio, Lucy Masto, Kathleen M M Vanni, Emily Kowalski, Grace Qian, Yuqing Zhang, Zachary S Wallace, Alí Duarte-García, Jeffrey A Sparks. (2022) Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study. The Lancet Rheumatology 4:11, e765-e774.
Online publication date: 1-Nov-2022.
Crossref
Clive Kelly. (2022) Increased risk of severe COVID-19 outcomes in patients with rheumatoid arthritis and interstitial lung disease. The Lancet Rheumatology 4:11, e741-e743.
Online publication date: 1-Nov-2022.
Crossref
L. A. Akulkina, M. Yu. Brovko, A. A. Schepalina, V. I. Sholomova, A. A. Kitbalian, A. S. Moiseev, P. P. Potapov, S. V. Moiseev. (2022) A case of severe COVID-19 in a patient with progressive fibrosing interstitial lung disease. PULMONOLOGIYA 32:5, 763-769.
Online publication date: 21-Sep-2022.
Crossref
Ying Wang, Yuqing Hao, Mengke Hu, Yadong Wang, Haiyan Yang. (2022) Interstitial lung disease independently associated with higher risk for COVID-19 severity and mortality: A meta-analysis of adjusted effect estimates. International Immunopharmacology 111, 109088.
Online publication date: 1-Oct-2022.
Crossref
V. Cottin, P. Bonniaud, J. Cadranel, B. Crestani, S. Jouneau, S. Marchand-Adam, H. Nunes, L. Wémeau-Stervinou, E. Bergot, E. Blanchard, R. Borie, A. Bourdin, C. Chenivesse, A. Clément, E. Gomez, A. Gondouin, S. Hirschi, F. Lebargy, C.-H. Marquette, D. Montani, G. Prévot, S. Quetant, M. Reynaud-Gaubert, M. Salaun, O. Sanchez, B. Trumbic, K. Berkani, P.-Y. Brillet, M. Campana, L. Chalabreysse, G. Chatté, D. Debieuvre, G. Ferretti, J.-M. Fourrier, N. Just, M. Kambouchner, B. Legrand, F. Le Guillou, J.-P. Lhuillier, A. Mehdaoui, J.-M. Naccache, C. Paganon, M. Rémy-Jardin, S. Si-Mohamed, P. Terrioux. (2022) Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire idiopathique – Actualisation 2021. Version intégrale. Revue des Maladies Respiratoires 39:7, e35-e106.
Online publication date: 1-Sep-2022.
Crossref
Monica L. Mullin, Andrew Churg, Christopher J. Ryerson. (2022) Management of fibrotic hypersensitivity pneumonitis. Current Opinion in Pulmonary Medicine 28:5, 421-431.
Online publication date: 22-Jul-2022.
Crossref
Naveen Dutt, Saumya Shishir, Nishant K Chauhan, Ramniwas Jalandra, Ashok kuwal, Pawan Garg, Deepak Kumar, Vikarn Vishwajeet, Amartya Chakraborti, Kunal Deokar, Shahir Asfahan, Avinash Babu, Pradeep bajad, Neeraj Gupta, Alkesh Khurana, Mahendra Kumar Garg. (2022) Mortality and Its Predictors in COVID-19 Patients With Pre-existing Interstitial Lung Disease. Cureus 194.
Online publication date: 7-Aug-2022.
Crossref
. (2022) Mortality among Patients with COVID-19 and Different Interstitial Lung Disease Subtypes: A Multicenter Cohort Study. Annals of the American Thoracic Society 19:8, 1435-1437.
Online publication date: 1-Aug-2022.
First Page | Full Text | PDF (538 KB) | Supplemental Material 
Saptarshi Sinha, Vanessa Castillo, Celia R. Espinoza, Courtney Tindle, Ayden G. Fonseca, Jennifer M. Dan, Gajanan D. Katkar, Soumita Das, Debashis Sahoo, Pradipta Ghosh. (2022) COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis. eBioMedicine 82, 104185.
Online publication date: 1-Aug-2022.
Crossref
Anna-Maria Hoffmann-Vold, Oliver Distler, Cosimo Bruni, Christopher P Denton, Jeska de Vries-Bouwstra, Marco Matucci Cerinic, Madelon C Vonk, Armando Gabrielli. (2022) Systemic sclerosis in the time of COVID-19. The Lancet Rheumatology 4:8, e566-e575.
Online publication date: 1-Aug-2022.
Crossref
. (2022) COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine 206:2, 219-221.
Online publication date: 15-Jul-2022.
First Page | Full Text | PDF (565 KB) | Supplemental Material 
Takafumi Yamaya, Eri Hagiwara, Tomohisa Baba, Tae Iwasawa, Takashi Ogura. (2022) Outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs. Journal of Infection and Chemotherapy 28:7, 1029-1032.
Online publication date: 1-Jul-2022.
Crossref
Rachel Strykowski, Divya C Patel, Manny Ribeiro Neto, Kerry M Hena, Mridu Gulati, LIsa A Maier, Karen Patterson. (2022) Rationale and design of the SARCoidosis Outcomes in all respiratory Viral Infectious Diseases (SARCOVID) Study. BMJ Open Respiratory Research 9:1, e001254.
Online publication date: 26-Jul-2022.
Crossref
Rachel Wallwork, Caoilfhionn M Connolly, Matthew Shneyderman, Zsuzsanna McMahan, Christopher A Mecoli, Fredrick Wigley, Laura K Hummers, Ami A Shah, Julie J Paik. (2022) Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis. The Lancet Rheumatology 4:7, e462-e464.
Online publication date: 1-Jul-2022.
Crossref
Kristina L. Bailey, Harlan Sayles, James Campbell, Neha Khalid, Madyson Anglim, Jana Ponce, Todd A. Wyatt, James C. McClay, Ellen L. Burnham, Alfred Anzalone, Corrine Hanson. (2022) COVID‐19 patients with documented alcohol use disorder or alcohol‐related complications are more likely to be hospitalized and have higher all‐cause mortality. Alcoholism: Clinical and Experimental Research 46:6, 1023-1035.
Online publication date: 2-May-2022.
Crossref
Horst Olschewski, Ernst Eber, Brigitte Bucher, Klaus Hackner, Sabin Handzhiev, Konrad Hoetzenecker, Marco Idzko, Walter Klepetko, Gabor Kovacs, Bernd Lamprecht, Judith Löffler-Ragg, Michael Meilinger, Alexander Müller, Christian Prior, Otmar Schindler, Helmut Täubl, Angela Zacharasiewicz, Ralf Harun Zwick, Britt-Madelaine Arns, Josef Bolitschek, Katharina Cima, Elisabeth Gingrich, Maximilian Hochmair, Fritz Horak, Peter Jaksch, Roland Kropfmüller, Andreas Pfleger, Bernhard Puchner, Christoph Puelacher, Patricia Rodriguez, Helmut J. F. Salzer, Peter Schenk, Ingrid Stelzmüller, Volker Strenger, Matthias Urban, Marlies Wagner, Franz Wimberger, Holger Flick. (2022) Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022). Wiener klinische Wochenschrift 134:9-10, 399-419.
Online publication date: 21-Apr-2022.
Crossref
Natalia Mena-Vázquez, Aimara García-Studer, Marta Rojas-Gimenez, Carmen María Romero-Barco, Sara Manrique-Arija, Arkaitz Mucientes, María Luisa Velloso-Feijoo, Francisco Javier Godoy-Navarrete, Pilar Morales-Garrido, Rocío Redondo-Rodríguez, MC Ordoñez-Cañizares, Rafaela Ortega-Castro, Jose Manuel Lisbona-Montañez, Ana Hidalgo Conde, Rocío Arnedo Díez de los Ríos, Eva Cabrera César, Francisco Espildora, María Carmen Aguilar-Hurtado, Isabel Añón-Oñate, Inmaculada Ureña-Garnica, Antonio Fernández-Nebro. (2022) Importance of Vaccination against SARS-CoV-2 in Patients with Interstitial Lung Disease Associated with Systemic Autoimmune Disease. Journal of Clinical Medicine 11:9, 2437.
Online publication date: 26-Apr-2022.
Crossref
Aykut Cilli, Ismail Hanta, Fatih Uzer, Funda Coskun, Can Sevinc, Pelin Pınar Deniz, Mehmet Parlak, Ersoy Altunok, Kemal Can Tertemiz, Ahmet Ursavas. (2022) Characteristics and outcomes of COVID-19 patients with IPF: A multi-center retrospective study. Respiratory Medicine and Research 81, 100900.
Online publication date: 1-May-2022.
Crossref
Rachel K Strykowski, Maria Poonawalla, Albina Tyker, Iazsmin Bauer Ventura, Cathryn Lee, Renea Jablonski, Rekha Vij, Jonathan Chung, Mary Strek, Ayodeji Adegunsoye. (2022) Mortality Risk From COVID-19 Among Unvaccinated Subjects With Autoimmune Phenotypes of Interstitial Lung Disease. Cureus 326.
Online publication date: 4-Apr-2022.
Crossref
Ivette Buendia-Roldan, Claudia Valenzuela, Moisés Selman. (2022) Pulmonary Fibrosis in the Time of COVID-19. Archivos de Bronconeumología 58, 6-7.
Online publication date: 1-Apr-2022.
Crossref
Eusebi Chiner-Vives, Rosa Cordovilla-Pérez, David de la Rosa-Carrillo, Marta García-Clemente, José Luis Izquierdo-Alonso, Remedios Otero-Candelera, Luis Pérez-de Llano, Jacobo Sellares-Torres, José Ignacio de Granda-Orive. (2022) Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases. Archivos de Bronconeumología 58, 39-50.
Online publication date: 1-Apr-2022.
Crossref
Joon Young Choi, Jin Woo Song, Chin Kook Rhee. (2022) Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease. Tuberculosis and Respiratory Diseases 85:2, 122-136.
Online publication date: 1-Apr-2022.
Crossref
Yoshiro Kai, Masayuki Matsuda, Kentaro Suzuki, Takehito Kasamatsu, Akihiro Kajita, Kenji Uno, Shigeo Muro. (2022) Tocilizumab and Baricitinib for Recovery From Acute Exacerbation of Combined Pulmonary Fibrosis and Emphysema Secondary to COVID-19 Infection: A Case Report. Cureus 12.
Online publication date: 22-Mar-2022.
Crossref
Katherine J. Myall, Jennifer L. Martinovic, Alex West. (2022) How COVID-19 interacts with interstitial lung disease. Breathe 18:1, 210158.
Online publication date: 7-Mar-2022.
Crossref
Noelle Ryan, Pauline Meskell. (2022) The experience of people with idiopathic pulmonary fibrosis living through the COVID‐19 pandemic. Journal of Advanced Nursing 2.
Online publication date: 18-Feb-2022.
Crossref
Marco Raffaele, Manlio Vinciguerra. (2022) The costs and benefits of senotherapeutics for human health. The Lancet Healthy Longevity 3:1, e67-e77.
Online publication date: 1-Jan-2022.
Crossref
Cong Liu, Junghwan Lee, Casey Ta, Ali Soroush, James R Rogers, Jae Hyun Kim, Karthik Natarajan, Jason Zucker, Yehoshua Perl, Chunhua Weng. (2022) Risk Factors Associated With SARS-CoV-2 Breakthrough Infections in Fully mRNA-Vaccinated Individuals: Retrospective Analysis. JMIR Public Health and Surveillance 8:5, e35311.
Online publication date: 24-May-2022.
Crossref
Sang Hyuk Kim, Byung Woo Jhun, Byeong-Ho Jeong, Hye Yun Park, Hojoong Kim, O Jung Kwon, Sun Hye Shin. (2022) The Higher Incidence of COVID-19 in Patients With Non-Tuberculous Mycobacterial Pulmonary Disease: A Single Center Experience in Korea. Journal of Korean Medical Science 37:32.
Online publication date: 1-Jan-2022.
Crossref
Claudia Valenzuela, Grant Waterer, Ganesh Raghu. (2021) Interstitial lung disease before and after COVID-19: a double threat?. European Respiratory Journal 58:6, 2101956.
Online publication date: 2-Dec-2021.
Crossref
Hyun Lee, Hayoung Choi, Bumhee Yang, Sun-Kyung Lee, Tai Sun Park, Dong Won Park, Ji-Yong Moon, Tae-Hyung Kim, Jang Won Sohn, Ho Joo Yoon, Sang-Heon Kim. (2021) Interstitial lung disease increases susceptibility to and severity of COVID-19. European Respiratory Journal 58:6, 2004125.
Online publication date: 22-Apr-2021.
Crossref
Mohamed Rafi Kathar Hussain, N. Kulasekaran, A. M. Anand, Padma Reka Danassegarane. (2021) COVID-19 causing acute deterioration of interstitial lung disease: a case report. Egyptian Journal of Radiology and Nuclear Medicine 52:1.
Online publication date: 8-Feb-2021.
Crossref
Linh T. Bui, Nichelle I. Winters, Mei-I Chung, Chitra Joseph, Austin J. Gutierrez, Arun C. Habermann, Taylor S. Adams, Jonas C. Schupp, Sergio Poli, Lance M. Peter, Chase J. Taylor, Jessica B. Blackburn, Bradley W. Richmond, Andrew G. Nicholson, Doris Rassl, William A. Wallace, Ivan O. Rosas, R. Gisli Jenkins, Naftali Kaminski, Jonathan A. Kropski, Nicholas E. Banovich, , Alexander V. Misharin, Alexander M. Tsankov, Avrum Spira, Pascal Barbry, Alvis Brazma, Christos Samakovlis, Douglas P. Shepherd, Emma L. Rawlins, Fabian J. Theis, Jennifer Griffonnet, Haeock Lee, Herbert B. Schiller, Paul Hofman, Joseph E. Powell, Joachim L. Schultze, Jeffrey Whitsett, Jiyeon Choi, Joakim Lundeberg, Naftali Kaminski, Jonathan A. Kropski, Nicholas E. Banovich, Jose Ordovas-Montanes, Jayaraj Rajagopal, Kerstin B. Meyer, Mark A. Krasnow, Kourosh Saeb‐Parsy, Kun Zhang, Robert Lafyatis, Sylvie Leroy, Muzlifah Haniffa, Martijn C. Nawijn, Marko Z. Nikolić, Maarten van den Berge, Malte Kuhnemund, Charles-Hugo Marquette, Michael Von Papen, Oliver Eickelberg, Orit Rosenblatt-Rosen, Paul A. Reyfman, Dana Pe’er, Peter Horvath, Purushothama Rao Tata, Aviv Regev, Mauricio Rojas, Max A. Seibold, Alex K. Shalek, Jason R. Spence, Sarah A. Teichmann, Stephen Quake, Thu Elizabeth Duong, Tommaso Biancalani, Tushar Desai, Xin Sun, Laure Emmanuelle Zaragosi. (2021) Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity. Nature Communications 12:1.
Online publication date: 14-Jul-2021.
Crossref
Cinzia Milito, Valentina Soccodato, Stefania Auria, Federica Pulvirenti, Isabella Quinti. (2021) COVID-19 in complex common variable immunodeficiency patients affected by lung diseases. Current Opinion in Allergy & Clinical Immunology 21:6, 535-544.
Online publication date: 27-Sep-2021.
Crossref
Yutaka Muto, Nobuyasu Awano, Minoru Inomata, Naoyuki Kuse, Mari Tone, Kohei Takada, Kazushi Fujimoto, Akihiro Ueda, Munehiro Hayashi, Takehiro Izumo. (2021) Predictive model for the development of critical coronavirus disease 2019 and its risk factors among patients in Japan. Respiratory Investigation 59:6, 804-809.
Online publication date: 1-Nov-2021.
Crossref
Lichen Ouyang, Jie Gong, Muqing Yu. (2021) Pre-existing interstitial lung disease in patients with coronavirus disease 2019: A meta-analysis. International Immunopharmacology 100, 108145.
Online publication date: 1-Nov-2021.
Crossref
Konstantinos Ntatsoulis, Theodoros Karampitsakos, Eliza Tsitoura, Elli-Anna Stylianaki, Alexios N. Matralis, Argyrios Tzouvelekis, Katerina Antoniou, Vassilis Aidinis. (2021) Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target. Frontiers in Immunology 12.
Online publication date: 4-Oct-2021.
Crossref
John A Mackintosh, Marc Lipman, David M Lowe, Elisabetta A Renzoni. (2021) Protecting the vulnerable: SARS-CoV-2 vaccination in immunosuppressed patients with interstitial lung disease. The Lancet Respiratory Medicine 9:9, 947-949.
Online publication date: 1-Sep-2021.
Crossref
E. Blanchard, A. Ozier, C. Janssen, B. Wyplosz, C. Andrejak. (2021) Vaccination COVID en pneumologie.. Revue des Maladies Respiratoires 38:7, 780-793.
Online publication date: 1-Sep-2021.
Crossref
Ioanna Nikitopoulou, Dionysios Fanidis, Konstantinos Ntatsoulis, Panagiotis Moulos, George Mpekoulis, Maria Evangelidou, Alice G. Vassiliou, Vasiliki Dimakopoulou, Edison Jahaj, Stamatios Tsipilis, Stylianos E. Orfanos, Ioanna Dimopoulou, Emmanouil Angelakis, Karolina Akinosoglou, Niki Vassilaki, Argyrios Tzouvelekis, Anastasia Kotanidou, Vassilis Aidinis. (2021) Increased Autotaxin Levels in Severe COVID-19, Correlating with IL-6 Levels, Endothelial Dysfunction Biomarkers, and Impaired Functions of Dendritic Cells. International Journal of Molecular Sciences 22:18, 10006.
Online publication date: 16-Sep-2021.
Crossref
Jeffrey A. Sparks, Zachary S. Wallace, Philip C. Robinson. (2021) Coronavirus disease 2019: update on coronavirus disease 2019 outcomes and vaccine efficacy in patients with immune-mediated inflammatory disease. Current Opinion in Rheumatology 33:5, 412-418.
Online publication date: 23-Jun-2021.
Crossref
Vivienne Kahlmann, Michael Manansala, Catharina C. Moor, Shiva Shahrara, Marlies S. Wijsenbeek, Nadera J. Sweiss. (2021) COVID-19 infection in patients with sarcoidosis: susceptibility and clinical outcomes. Current Opinion in Pulmonary Medicine 27:5, 463-471.
Online publication date: 8-Jul-2021.
Crossref
Simona Granata, Pierluigi Carratù, Giovanni Stallone, Gianluigi Zaza. (2021) mTOR-Inhibition and COVID-19 in Kidney Transplant Recipients: Focus on Pulmonary Fibrosis. Frontiers in Pharmacology 12.
Online publication date: 23-Aug-2021.
Crossref
Syeda Fatima Naqvi, Dhairya A Lakhani, Amir Humza Sohail, James Maurer, Sarah Sofka, Arif Sarwari, Yousaf B Hadi. (2021) Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: a propensity matched multicentre research network analysis. BMJ Open Respiratory Research 8:1, e000969.
Online publication date: 9-Aug-2021.
Crossref
Stephen Machnicki, Dhara Patel, Anup Singh, Arunabh Talwar, Bushra Mina, Margarita Oks, Priyanka Makkar, David Naidich, Atul Mehta, Nicholas S. Hill, Kevin K. Brown, Suhail Raoof. (2021) The Usefulness of Chest CT Imaging in Patients With Suspected or Diagnosed COVID-19. Chest 160:2, 652-670.
Online publication date: 1-Aug-2021.
Crossref
. (2021) Update in COVID-19 2020. American Journal of Respiratory and Critical Care Medicine 203:12, 1462-1471.
Online publication date: 25-Jun-2021.
First Page | Full Text | PDF (792 KB) | Supplemental Material 
Ennio Giulio Favalli, Gabriella Maioli, Martina Biggioggero, Roberto Caporali. (2021) Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic. Expert Review of Clinical Immunology 17:6, 561-571.
Online publication date: 14-Apr-2021.
Crossref
. (2021) Update in Interstitial Lung Disease 2020. American Journal of Respiratory and Critical Care Medicine 203:11, 1343-1352.
Online publication date: 4-Jun-2021.
First Page | Full Text | PDF (654 KB) | Supplemental Material 
Max Thomas, Oliver J Price, James H Hull. (2021) Pulmonary function and COVID-19. Current Opinion in Physiology 21, 29-35.
Online publication date: 1-Jun-2021.
Crossref
Felipe Villar-Álvarez, Miguel Ángel Martínez-García, David Jiménez, Fernando Fariñas-Guerrero, Raúl Ortiz de Lejarazu-Leonardo, José Luis López-Campos, Marina Blanco-Aparicio, Íñigo Royo-Crespo, Alberto García-Ortega, Antoni Trilla-García, Juan Carlos Trujillo-Reyes, María Fernández-Prada, David Díaz-Pérez, Rosalía Laporta-Hernández, Claudia Valenzuela, Rosario Menéndez, David de la Rosa-Carrillo. (2021) Recomendaciones SEPAR sobre la vacuna COVID-19 en las enfermedades respiratorias. Open Respiratory Archives 3:2, 100097.
Online publication date: 1-Apr-2021.
Crossref
Sarah MacIsaac, Martin Kolb. (2021) Interstitial lung disease. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 5:2, 93-96.
Online publication date: 5-Apr-2021.
Crossref
João Fadista, Luke M. Kraven, Juha Karjalainen, Shea J. Andrews, Frank Geller, J Kenneth Baillie, Louise V. Wain, R.Gisli Jenkins, Bjarke Feenstra. (2021) Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity. EBioMedicine 65, 103277.
Online publication date: 1-Mar-2021.
Crossref
Spyros A. Papiris, Demosthenes Bouros, Katerina Markopoulou, Lykourgos Kolilekas, Andriana I. Papaioannou, Vasilios Tzilas, Argyrios Tzouvelekis, Eva Fouka, Despoina Papakosta, Zoe Daniil, Paschalis Steiropoulos, Athina Gogali, Ilias C. Papanikolaou, Areti Xyfteri, Aggeliki Haritou, Ioanna Korbila, Ioannis P. Tomos, Stylianos Loukides, Rita Bellelli, Georgia Kounti, Christina Rampiadou, Theodoros Karampitsakos, Ilias Dimeas, Paraskevi Kirgou, Andromachi Bompoki, Eirini Vasarmidi, Konstantinos Loverdos, Elvira-Markela Antonogiannaki, Myrto Blizou, Evangelos Bouros, Konstantinos Kagouridis, Maria Maniati, Anna Karakatsani, Katerina M. Antoniou, Effrosyni D. Manali. (2021) Early COVID-19 lockdown in Greece and idiopathic pulmonary fibrosis: a beneficial “impact” beyond any expectation. European Respiratory Journal 57:3, 2003111.
Online publication date: 17-Dec-2020.
Crossref
Rajen N. Naidoo, Mohamed F. Jeebhay. (2021) COVID-19: a new burden of respiratory disease among South African miners?. Current Opinion in Pulmonary Medicine 27:2, 79-87.
Online publication date: 7-Jan-2021.
Crossref
Ya‐dong Gao, Mei Ding, Xiang Dong, Jin‐jin Zhang, Ahmet Kursat Azkur, Dilek Azkur, Hui Gan, Yuan‐li Sun, Wei Fu, Wei Li, Hui‐ling Liang, Yi‐yuan Cao, Qi Yan, Can Cao, Hong‐yu Gao, Marie‐Charlotte Brüggen, Willem van de Veen, Milena Sokolowska, Mübeccel Akdis, Cezmi A. Akdis. (2021) Risk factors for severe and critically ill COVID‐19 patients: A review. Allergy 76:2, 428-455.
Online publication date: 4-Dec-2020.
Crossref
ZarirFarokh Udwadia, ParvaizA Koul, Sahajal Dhooria. (2021) The impact of COVID-19 on patients with preexisting interstitial lung disease: High mortality in these high-risk patients. Lung India 38:7, 1.
Online publication date: 1-Jan-2021.
Crossref
Comments Post a Comment




New User Registration

Not Yet Registered?
Benefits of Registration Include:
 •  A Unique User Profile that will allow you to manage your current subscriptions (including online access)
 •  The ability to create favorites lists down to the article level
 •  The ability to customize email alerts to receive specific notifications about the topics you care most about and special offers
American Journal of Respiratory and Critical Care Medicine
202
12

Click to see any corrections or updates and to confirm this is the authentic version of record